Abstract

The aim of the present study was to improve the solubility and dissolution rate of a poorly water soluble drug, telmisartan by solid dispersion technique. The objective of the study is to prepare telmisartan solid dispersion and encapsulation using different polymers to achieve the enhanced solubility and to determine the Kinetic Modeling of Drug Release and Stability studies. Telmisartan has PH dependent solubility. Due to this reason only the % release for the prepared solid dispersions was higher in PH 4.5 acetate buffer when compared with other mediums. Based on mathematical data revealed from models, it was concluded that the release data was best fitted with First order kinetics. Stability studies showed that there were no significant changes in physical and chemical properties of capsule of formulation after 3 months.

Keywords: Solid dispersion; Telmisartan; PEG6000; PEG20000; HPMC E15; HPC LH21; β-Cyclodextrin

References

1. Alfred Martin. “Physical pharmacy, fifth edition, Lippincott, Williams and Wilking, New York (2007): 230-245, 337-345.
2. Michael E Aulton. “Pharmaceutics the science of dosage form design”. Second edition, Churchill Living stone, New York (2002): 15-32.
3. James Swarbrick and James Boylan. “Encyclopedia of pharmaceutical technology second edition”. Marcel Dakker, Ic, Volume 1 (2002): 717-727.
4. DM Brahmankar and Sunil B Jaiswal. “Biopharmaceutics and pharmacokinetics A treatise”. First edition, Vallabh Prakashan, Delhi (1995): 19-25.
5. Gong Y., et al. “Principles of Solubility”. In: P Augustijns, ME Brewster (Eds.), Solvent Systems and Their Selection in Pharmaceutics and Biopharmaceutics, Springer Science + Business Media, LLC, New York (2007): 1-27.
6. USP 28-NF 23. The United States Pharmacopoeial Convention, Rockville (2005): 2875.
7. Vasconcelos T., et al. “Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs”. Drug Discovery Today 12.23-24 (2007): 1068-1075.
8. Serajuddin ATM. “Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs”. Journal of Pharmaceutical Sciences 88 (1999): 1058-1066.
9. “Indomethacin using gelucire 50/13 and PEG 4000”. Saudhi Pharmaceutical Journal 17: 217-225.
10. Rahul Gaste. “An overview on solid dispersions” (2009). 
11. Newa M., et al. “Enhancement of Solubility, Dissolution and Bioavailability of Ibuprofen in Solid Dispersion Systems”. Chemical and Pharmaceutical Bulletin 56.4 (2008): 569-574.

Citation

Citation: Kabita Banik and K Yashasree. “Formulation and Evalution of Telmisartan Solid Dispersion of Encapsulation Using Different Polymer". Acta Scientific Pharmaceutical Sciences 4.7 (2020): 41-48.

Copyright

Copyright: © 2020 Kabita Banik and K Yashasree. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.